Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Frontiers in CAR-T cell therapy for autoimmune diseases
Yan-Ruide Li, Zibai Lyu, Yuning Chen, et al.
Trends in Pharmacological Sciences (2024) Vol. 45, Iss. 9, pp. 839-857
Open Access | Times Cited: 13

Showing 13 citing articles:

Boosting CAR-T cell therapy through vaccine synergy
Yan-Ruide Li, Zibai Lyu, Xinyuan Shen, et al.
Trends in Pharmacological Sciences (2025)
Open Access | Times Cited: 2
Automated manufacturing of cell therapies
Alice Melocchi, Brigitte Schmittlein, Sudeshna Sadhu, et al.
Journal of Controlled Release (2025)
Open Access | Times Cited: 1
Defining immune reset: achieving sustained remission in autoimmune diseases
Tobias Junt, Thomas Calzascia, Elisabetta Traggiai, et al.
Nature reviews. Immunology (2025)
Closed Access | Times Cited: 1
Challenges and opportunities in single-domain antibody-based tumor immunotherapy
Xiaozhi Xi, Guo Shu-hua, Yuchao Gu, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025), pp. 189284-189284
Closed Access
Synthetic Receptor-Based Cell Therapies for Autoimmune Diseases: An Update
Mieszko Lachota, Radosław Zagożdżon
Cytotherapy (2025)
Open Access
A new therapeutic pathway in autoimmune diseases: chimeric antigen receptor T cells (CAR-T) targeting specific cell subtypes or antigen-specific B lymphocytes—a brief review
María Fernanda Segovia, Diana Landoni, Yohana Defranchi, et al.
Exploration of Immunology (2025) Vol. 5
Open Access
Advances And Challenges in Immunosuppressive Antibody Drug Conjugates
Aiman A. Yaseen, L. Nathan Tumey
European Journal of Medicinal Chemistry (2025), pp. 117576-117576
Closed Access
CD8+ T cell-based immunotherapy: Promising frontier in human diseases
Nu Quynh Chau Ton, Gitima Deka, Pil‐Hoon Park
Biochemical Pharmacology (2025), pp. 116909-116909
Closed Access
Diverse potential of chimeric antigen receptor‐engineered cell therapy: Beyond cancer
Lvying Wu, Lingfeng Zhu, Jin Chen
Clinical and Translational Medicine (2025) Vol. 15, Iss. 4
Open Access
Epigenetically Reprogrammed Nanovesicles as Inverse Vaccines for Antigen-Specific Immune Tolerance in Autoimmune Diseases
Yue Xi, Hui Feng, Xue Liu, et al.
Nano Letters (2025)
Closed Access
Chimeric antigen receptor T-cell therapy in autoimmune diseases
Jie Liu, Zhao Yan, Zhao Hai
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
CAR-T cell therapy : recent updates and challenges in autoimmune diseases
Blandine Caël, Elodie Bôle‐Richard, Francine Garnache‐Ottou, et al.
Journal of Allergy and Clinical Immunology (2024)
Closed Access | Times Cited: 1
Advances in Preventive and Therapeutic Strategies for Oral Cancer: A Short Review
Lei Ma, Myoung-Ok Kim
Journal of Cancer Prevention (2024) Vol. 29, Iss. 4, pp. 113-119
Open Access
Page 1

Scroll to top